[ad_1]
Drug developer Cingulate said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for attention deficit hyperactivity disorder, citing…
Reuters Health Information
[ad_2]
Source link : https://www.medscape.com/s/viewarticle/fda-declines-approve-cingulates-adhd-treatment-over-2026a1000icx?src=rss
Author :
Publish date : 2026-06-02 12:08:00
Copyright for syndicated content belongs to the linked Source.